-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B7ZWGK7IUsD12jQwHIK9EEuMODI1ZyFWNIE/kfb8swY3j4PjKHVx5JSn/dhKoJmm iyGpIfNRbihZSHdM0OIc6g== 0000891836-97-000595.txt : 19971217 0000891836-97-000595.hdr.sgml : 19971217 ACCESSION NUMBER: 0000891836-97-000595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19971031 FILED AS OF DATE: 19971216 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COULTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000942416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943219075 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-21905 FILM NUMBER: 97738903 BUSINESS ADDRESS: STREET 1: 550 CALIFORNIA AVE STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 4158427300 MAIL ADDRESS: STREET 1: 550 CALIFORNIA AVE STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 COMPANY DATA: COMPANY CONFORMED NAME: COULTER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000942416 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] OWNER IRS NUMBER: 943219075 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 550 CALIFORNIA AVE STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 4158427300 MAIL ADDRESS: STREET 1: 550 CALIFORNIA AVE STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 4 1 FORM 4 :----------: :---------------------------: : FORM 4 : : OMB APPROVAL : :----------: :---------------------------: :OMB NUMBER 3235-0287 : :EXPIRES: SEPTEMBER 30, 1998: :ESTIMATED AVERAGE BURDEN : :HOURS PER RESPONSE.... 0.5 : :---------------------------: U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |_| CHECK THIS BOX IF NO LONGER SUBJECT TO SECTION 16. FORM 4 OR FORM 5 OBLIGATIONS MAY CONTINUE. SEE INSTRUCTION 1(B). ================================================================================ 1. Name and Address of Reporting Person Coulter, III Joseph R. ----------------------------------------------------------------------------- (Last) (First) (Middle) c/o Coulter Pharmaceutical, Inc. 550 California Avenue, Suite 200 ----------------------------------------------------------------------------- (Street) Palo Alto CA 94306 ----------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol Coulter Pharmaceutical, Inc. ("CLTR") ----------------------------------------------------------------------------- ================================================================================ 3. IRS or Social Security Number of Reporting Person (Voluntary) ----------------------------------------------------------------------------- ================================================================================ 4. Statement for Month/Year October/1997 ----------------------------------------------------------------------------- ================================================================================ 5. If Amendment, Date of Original (Month/Year) ----------------------------------------------------------------------------- ================================================================================ 6. Relationship of Reporting Person(s) Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (Specify below) ----------------------------------------------------------------------------- ================================================================================ 7. Individual or Joint/Group Filing (Check Applicable Line) __X__ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person ================================================================================ TABLE I-NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
1.Title of Security 2.Trans- 3.Trans- 4.Securities Acquired (A) 5.Amount of 6.Ownership 7.Nature of (Instr. 3) action action or Disposed of (D) Securities Bene- Form: Direct Indirect Date Code (Instr. 3, 4 and 5) ficially Owned (D) or Beneficial (Month/ (Instr. 8) ------------------------ at End of Indirect (I) Ownership Day/ ------------ Amount (A) or Price Month (Instr. (Instr. 4) (Instr. 4) Year) Code V (D) 3 and 4) - ------------------- --------- ------------ ------------------------ ------------------ -------------- --------------- Common Stock 10/31/97 J(1) 1,666,666 D 0 I (1) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 10/31/97 J(2) 951,334 A 955,176 I (2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 10/31/97 J(3) 326,166 A 326,166 I (3) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 3,842 D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 3,842 I (4) - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) * If the form is filed by more than one reporting person, see Instruction 4(b)(v). (1) These 1,666,666 shares disposed of were held by Coulter Corporation, of which Mr. Coulter was a director, officer and beneficial stockholder. In connection with the acquisition of the stock of Coulter Corporation by Beckman Instruments, Inc. and immediately prior to the consummation of such acquisition, Coulter Corporation paid a dividend to its former stockholders comprised of the 1,666,666 shares of common stock to which this Form 4 relates. (2) These securities are held by the Coulter Family Limited Partnership. Mr. Coulter is co-trustee of the Joseph R. Coulter, Jr. Trust, which is a co-general partner of the Coulter Family Limited Partnership. The Coulter Family Limited Partnership acquired these securities as a dividend paid upon the shares of Coulter Corporation's stock in connection with the sale of the stock of Coulter Corporation to Beckman Instruments, Inc. (3) These securities are held by the Joseph R. Coulter, Jr. Trust. Mr. Coulter is co-trustee of the Joseph R. Coulter, Jr. Trust, which acquired these securities as a dividend paid upon the shares of Coulter Corporation's stock in connection with the sale of the stock of Coulter Corporation to Beckman Instruments, Inc. (4) These shares are held by Susan Sekman Coulter, the reporting person's wife. (5) The option vests in four annual installments beginning on July 30, 1998.
SEC 1474 (7/96) FORM 4 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) 1. Title of Derivative Security (Instr. 3) Option (right to buy) --------------------------------------------------------------------------- ================================================================================ 2. Conversion or Exercise Price of Derivative Security $8.625 --------------------------------------------------------------------------- ================================================================================ 3. Transaction Date (Month/Day/Year) 7/30/97 --------------------------------------------------------------------------- ================================================================================ 4. Transaction Code (Instr. 8) Code V ------------------ ------------ A ================================================================================ 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) (A) (D) ------------------ ------------ 10,000 ================================================================================ 6. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable Expiration Date ------------------------ ------------------------ (5) 7/30/07 ================================================================================ 7. Title and Amount of Underlying Securities (Instr. 3 and 4) Title Amount or Number of Shares ------------------ -------------------------- Common Stock 10,000 ================================================================================ 8. Price of Derivative Security (Instr. 5) ================================================================================ 9. Number of Derivative Securities Beneficially Owned at End of Month (Instr. 4) --------------------------------------------------------------------------- ================================================================================ 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) D --------------------------------------------------------------------------- ================================================================================ 11. Nature of Indirect Beneficial Ownership (Instr. 4) --------------------------------------------------------------------------- ================================================================================ Explanation of Responses: /s/ Joseph R. Coulter, III 12/12/97 --------------------------------------- --------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 2 SEC 1474 (7/96) Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. -----END PRIVACY-ENHANCED MESSAGE-----